id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-4562-0024,FDA,FDA-2015-D-4562,Public Workshop on Safety Assessment for Investigational New Drug Safety Reporting; Correction,Notice,Correction,2017-12-14T05:00:00Z,2017,12,2017-12-14T05:00:00Z,,2017-12-14T17:33:45Z,2017-26938,0,0,0900006482d08e78
FDA-2015-D-4562-0022,FDA,FDA-2015-D-4562,Meetings: Safety Assessment for Investigational New Drug Safety Reporting; Public Workshop,Notice,Announcement,2017-11-27T05:00:00Z,2017,11,2017-11-27T05:00:00Z,,2017-11-27T14:49:30Z,2017-25454,0,0,0900006482cae426
FDA-2015-D-4562-0003,FDA,FDA-2015-D-4562,Request for Extension from Biotechnology Innovation Organization (BIO) and Pharmaceutical and Research Manufacturers of America (PhRMA),Other,Request for Extension,2016-02-03T05:00:00Z,2016,2,2016-02-03T05:00:00Z,,2016-02-03T21:38:43Z,,0,0,0900006481e3ba89
FDA-2015-D-4562-0001,FDA,FDA-2015-D-4562,"Safety Assessment for Investigational New Drug Application Safety
Reporting; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2015-12-17T05:00:00Z,2015,12,2015-12-17T05:00:00Z,2016-02-17T04:59:59Z,2016-02-17T22:01:26Z,2015-31690,0,0,0900006481db6ac5
FDA-2015-D-4562-0002,FDA,FDA-2015-D-4562,Safety Assessment for IND Safety Reporting Guidance for Industry,Other,Guidance,2015-12-17T05:00:00Z,2015,12,2015-12-17T05:00:00Z,,2024-11-11T21:16:20Z,,1,0,0900006481db7079